Novel siRNA backbone developed at UMass Chan enhances stability, durability of potentially therapeutic platform
A biochemical breakthrough using simple carbon atoms by Ken Yamada, PhD, and Anastasia Khvorova, PhD, has dramatically improved the stability and efficacy of a potential oligonucleotide therapeutic platform in mice.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Anastasia Khvorova, RNA Therapeutics Institute, Latest News, Top Stories, Ken Yamada,
